US Stock MarketDetailed Quotes

INZY Inozyme Pharma

Watchlist
  • 3.030
  • +0.050+1.68%
Close Dec 13 16:00 ET
  • 2.990
  • -0.040-1.32%
Post 20:01 ET
194.65MMarket Cap-1.95P/E (TTM)

Inozyme Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-30.00%-24.53M
-52.16%-23.66M
-38.04%-24.53M
-22.36%-70.68M
-28.38%-18.49M
-30.00%-18.87M
-5.86%-15.55M
-25.51%-17.77M
-19.95%-57.76M
-7.11%-14.4M
Net income from continuing operations
-47.67%-24.57M
-73.48%-27.03M
-34.15%-23.35M
-6.13%-71.17M
-16.18%-21.54M
-1.62%-16.64M
-2.11%-15.58M
-3.08%-17.4M
-18.43%-67.06M
1.12%-18.54M
Operating gains losses
----
----
----
17.65%20K
----
----
----
----
--17K
--13K
Depreciation and amortization
-6.25%195K
-10.05%188K
-12.08%182K
11.96%833K
5.56%209K
10.05%208K
16.76%209K
16.29%207K
10.39%744K
8.79%198K
Other non cash items
45.05%454K
56.79%439K
101.52%397K
113.69%1.12M
85.56%334K
128.47%313K
164.15%280K
91.26%197K
39.15%526K
81.82%180K
Change In working capital
34.67%-1.92M
327.26%2.16M
36.73%-1.34M
-253.18%-3.08M
19.10%2.93M
-1,751.12%-2.94M
31.61%-950K
-376.14%-2.12M
2,267.06%2.01M
-17.67%2.46M
-Change in prepaid assets
69.38%-890K
-317.24%-726K
283.17%1.18M
-421.71%-2.02M
-20.49%753K
-31.78%-2.91M
-132.10%-174K
-6.36%309K
20.21%-387K
127.64%947K
-Change in payables and accrued expense
-563.01%-801K
689.02%3.11M
-7.06%-2.3M
-104.09%-123K
51.37%2.38M
-93.20%173K
69.39%-528K
-450.49%-2.15M
151.42%3.01M
-42.43%1.58M
-Change in other current liabilities
-11.71%-229K
9.27%-225K
20.00%-220K
-54.61%-940K
-221.21%-212K
-11.41%-205K
-37.02%-248K
-55.37%-275K
2.88%-608K
60.95%-66K
Cash from discontinued investing activities
Operating cash flow
-30.00%-24.53M
-52.16%-23.66M
-38.04%-24.53M
-22.36%-70.68M
-28.38%-18.49M
-30.00%-18.87M
-5.86%-15.55M
-25.51%-17.77M
-19.95%-57.76M
-7.11%-14.4M
Investing cash flow
Cash flow from continuing investing activities
152.33%23.35M
209.12%17.82M
-24.50%10.39M
-892.89%-53.65M
-301.06%-6.47M
-440.33%-44.62M
28.78%-16.33M
-38.99%13.77M
-112.63%-5.4M
-66.08%3.22M
Net PPE purchase and sale
-85.71%-13K
--0
81.71%-32K
27.32%-298K
-128.26%-105K
95.24%-7K
94.50%-11K
-929.41%-175K
-3.27%-410K
-15.00%-46K
Net investment purchase and sale
152.37%23.36M
209.19%17.82M
-25.21%10.43M
-968.46%-53.35M
-295.01%-6.37M
-450.04%-44.61M
28.21%-16.32M
-38.26%13.94M
-111.56%-4.99M
-65.74%3.26M
Cash from discontinued investing activities
Investing cash flow
152.33%23.35M
209.12%17.82M
-24.50%10.39M
-892.89%-53.65M
-301.06%-6.47M
-440.33%-44.62M
28.78%-16.33M
-38.99%13.77M
-112.63%-5.4M
-66.08%3.22M
Financing cash flow
Cash flow from continuing financing activities
-84.91%10.52M
-98.06%458K
-99.21%159K
73.06%125.97M
12.52M
1,553.97%69.72M
-65.40%23.64M
8,273.33%20.1M
11,852.05%72.79M
0
Net issuance payments of debt
--0
--0
--0
887.65%40M
--12.5M
--0
--7.5M
--20M
--4.05M
--0
Net common stock issuance
-84.99%10.44M
----
----
52.57%85.65M
---2K
165,723.81%69.56M
----
----
--56.14M
--0
Proceeds from stock option exercised by employees
-45.75%83K
732.73%458K
65.63%159K
-97.44%322K
--18K
-26.09%153K
-99.55%55K
-60.00%96K
1,969.13%12.6M
--0
Cash from discontinued financing activities
Financing cash flow
-84.91%10.52M
-98.06%458K
-99.21%159K
73.06%125.97M
--12.52M
1,553.97%69.72M
-65.40%23.64M
8,273.33%20.1M
11,852.05%72.79M
--0
Net cash flow
Beginning cash position
-62.23%15.54M
-57.61%20.93M
4.90%34.9M
40.55%33.27M
6.32%47.21M
-34.65%41.16M
52.89%49.38M
40.55%33.27M
-16.64%23.67M
60.96%44.4M
Current changes in cash
49.92%9.34M
34.60%-5.38M
-186.89%-13.98M
-82.88%1.65M
-11.26%-12.44M
133.58%6.23M
-126.80%-8.23M
86.18%16.09M
302.70%9.62M
-183.38%-11.18M
Effect of exchange rate changes
99.45%-1K
-109.09%-1K
-47.37%10K
28.00%-18K
152.83%134K
-810.00%-182K
125.58%11K
226.67%19K
-204.17%-25K
60.61%53K
End cash Position
-47.28%24.89M
-62.23%15.54M
-57.61%20.93M
4.90%34.9M
4.90%34.9M
6.32%47.21M
-34.65%41.16M
52.89%49.38M
40.55%33.27M
40.55%33.27M
Free cash flow
-30.02%-24.54M
-52.05%-23.66M
-36.88%-24.57M
-22.01%-70.97M
-28.70%-18.59M
-28.74%-18.88M
-4.51%-15.56M
-26.59%-17.95M
-19.82%-58.17M
-7.13%-14.45M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -30.00%-24.53M-52.16%-23.66M-38.04%-24.53M-22.36%-70.68M-28.38%-18.49M-30.00%-18.87M-5.86%-15.55M-25.51%-17.77M-19.95%-57.76M-7.11%-14.4M
Net income from continuing operations -47.67%-24.57M-73.48%-27.03M-34.15%-23.35M-6.13%-71.17M-16.18%-21.54M-1.62%-16.64M-2.11%-15.58M-3.08%-17.4M-18.43%-67.06M1.12%-18.54M
Operating gains losses ------------17.65%20K------------------17K--13K
Depreciation and amortization -6.25%195K-10.05%188K-12.08%182K11.96%833K5.56%209K10.05%208K16.76%209K16.29%207K10.39%744K8.79%198K
Other non cash items 45.05%454K56.79%439K101.52%397K113.69%1.12M85.56%334K128.47%313K164.15%280K91.26%197K39.15%526K81.82%180K
Change In working capital 34.67%-1.92M327.26%2.16M36.73%-1.34M-253.18%-3.08M19.10%2.93M-1,751.12%-2.94M31.61%-950K-376.14%-2.12M2,267.06%2.01M-17.67%2.46M
-Change in prepaid assets 69.38%-890K-317.24%-726K283.17%1.18M-421.71%-2.02M-20.49%753K-31.78%-2.91M-132.10%-174K-6.36%309K20.21%-387K127.64%947K
-Change in payables and accrued expense -563.01%-801K689.02%3.11M-7.06%-2.3M-104.09%-123K51.37%2.38M-93.20%173K69.39%-528K-450.49%-2.15M151.42%3.01M-42.43%1.58M
-Change in other current liabilities -11.71%-229K9.27%-225K20.00%-220K-54.61%-940K-221.21%-212K-11.41%-205K-37.02%-248K-55.37%-275K2.88%-608K60.95%-66K
Cash from discontinued investing activities
Operating cash flow -30.00%-24.53M-52.16%-23.66M-38.04%-24.53M-22.36%-70.68M-28.38%-18.49M-30.00%-18.87M-5.86%-15.55M-25.51%-17.77M-19.95%-57.76M-7.11%-14.4M
Investing cash flow
Cash flow from continuing investing activities 152.33%23.35M209.12%17.82M-24.50%10.39M-892.89%-53.65M-301.06%-6.47M-440.33%-44.62M28.78%-16.33M-38.99%13.77M-112.63%-5.4M-66.08%3.22M
Net PPE purchase and sale -85.71%-13K--081.71%-32K27.32%-298K-128.26%-105K95.24%-7K94.50%-11K-929.41%-175K-3.27%-410K-15.00%-46K
Net investment purchase and sale 152.37%23.36M209.19%17.82M-25.21%10.43M-968.46%-53.35M-295.01%-6.37M-450.04%-44.61M28.21%-16.32M-38.26%13.94M-111.56%-4.99M-65.74%3.26M
Cash from discontinued investing activities
Investing cash flow 152.33%23.35M209.12%17.82M-24.50%10.39M-892.89%-53.65M-301.06%-6.47M-440.33%-44.62M28.78%-16.33M-38.99%13.77M-112.63%-5.4M-66.08%3.22M
Financing cash flow
Cash flow from continuing financing activities -84.91%10.52M-98.06%458K-99.21%159K73.06%125.97M12.52M1,553.97%69.72M-65.40%23.64M8,273.33%20.1M11,852.05%72.79M0
Net issuance payments of debt --0--0--0887.65%40M--12.5M--0--7.5M--20M--4.05M--0
Net common stock issuance -84.99%10.44M--------52.57%85.65M---2K165,723.81%69.56M----------56.14M--0
Proceeds from stock option exercised by employees -45.75%83K732.73%458K65.63%159K-97.44%322K--18K-26.09%153K-99.55%55K-60.00%96K1,969.13%12.6M--0
Cash from discontinued financing activities
Financing cash flow -84.91%10.52M-98.06%458K-99.21%159K73.06%125.97M--12.52M1,553.97%69.72M-65.40%23.64M8,273.33%20.1M11,852.05%72.79M--0
Net cash flow
Beginning cash position -62.23%15.54M-57.61%20.93M4.90%34.9M40.55%33.27M6.32%47.21M-34.65%41.16M52.89%49.38M40.55%33.27M-16.64%23.67M60.96%44.4M
Current changes in cash 49.92%9.34M34.60%-5.38M-186.89%-13.98M-82.88%1.65M-11.26%-12.44M133.58%6.23M-126.80%-8.23M86.18%16.09M302.70%9.62M-183.38%-11.18M
Effect of exchange rate changes 99.45%-1K-109.09%-1K-47.37%10K28.00%-18K152.83%134K-810.00%-182K125.58%11K226.67%19K-204.17%-25K60.61%53K
End cash Position -47.28%24.89M-62.23%15.54M-57.61%20.93M4.90%34.9M4.90%34.9M6.32%47.21M-34.65%41.16M52.89%49.38M40.55%33.27M40.55%33.27M
Free cash flow -30.02%-24.54M-52.05%-23.66M-36.88%-24.57M-22.01%-70.97M-28.70%-18.59M-28.74%-18.88M-4.51%-15.56M-26.59%-17.95M-19.82%-58.17M-7.13%-14.45M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion--------Unqualified Opinion--
Heat List
US
Overall
Symbol
Price
% Chg

No Data